Research location
Xenia
Ohio, United States
Advertisement
Research activity in Xenia
Ohio, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 89 trials and 89 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Xenia
89 linked trials · page 1 of 2Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAsNCT02515773 · 2015-12-01 · 1 site observation
COMPLETED
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentNCT01573442 · 2013-09-10 · 1 site observation
COMPLETED
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone TherapyNCT01598298 · 2013-05-15 · 1 site observation
COMPLETED
S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast CancerNCT01515800 · 2012-05-01 · 1 site observation
COMPLETED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone ThpyNCT01385137 · 2012-02-01 · 1 site observation
COMPLETED
Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast CancerNCT01439945 · 2011-09-01 · 1 site observation
COMPLETED
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal SymptomsNCT01376349 · 2011-07-01 · 1 site observation
COMPLETED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08 · 1 site observation
COMPLETED
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerNCT01124695 · 2011-01-07 · 1 site observation
COMPLETED
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerNCT01120236 · 2010-12-01 · 1 site observation
COMPLETED
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung CancerNCT01107626 · 2010-10-25 · 1 site observation
COMPLETED
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerNCT01091454 · 2010-06-01 · 1 site observation
COMPLETED
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast CancerNCT01086605 · 2010-05-01 · 1 site observation
COMPLETED
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerNCT00856492 · 2010-04-01 · 1 site observation
COMPLETED
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaNCT01064648 · 2010-03-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabNCT01009918 · 2010-03-01 · 1 site observation
COMPLETED
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerNCT01041781 · 2010-02-01 · 1 site observation
TERMINATED
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen TherapyNCT00956813 · 2009-10-01 · 1 site observation
COMPLETED
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoNCT00775645 · 2009-09-01 · 1 site observation
COMPLETED
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryNCT00861705 · 2009-07-21 · 1 site observation
COMPLETED
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerNCT00946712 · 2009-07-15 · 1 site observation
TERMINATED
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerNCT00942331 · 2009-07-15 · 1 site observation
COMPLETED
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerNCT00881361 · 2009-07-01 · 1 site observation
COMPLETED
Treatment With Pazopanib for Neoadjuvant Breast CancerNCT00849472 · 2009-07-01 · 1 site observation
COMPLETED
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin LymphomaNCT00822120 · 2009-07-01 · 1 site observation
COMPLETED
S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00828139 · 2009-05-01 · 1 site observation
COMPLETED
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206 · 2009-03-01 · 1 site observation
COMPLETED
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryNCT00770809 · 2009-02-24 · 1 site observation
COMPLETED
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerNCT00820872 · 2009-02-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10 · 1 site observation
COMPLETED
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesNCT00874211 · 2008-12-01 · 1 site observation
COMPLETED
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By SurgeryNCT00770120 · 2008-12-01 · 1 site observation
COMPLETED
Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00798603 · 2008-12-01 · 1 site observation
COMPLETED
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerNCT00662129 · 2008-11-01 · 1 site observation
COMPLETED
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung CancerNCT00792701 · 2008-11-01 · 1 site observation
COMPLETED
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast CancerNCT00699491 · 2008-10-31 · 1 site observation
COMPLETED
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerNCT00785291 · 2008-10-13 · 1 site observation
COMPLETED
Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerNCT00776100 · 2008-10-01 · 1 site observation
TERMINATED
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerNCT00738881 · 2008-10-01 · 1 site observation
TERMINATED
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerNCT00601900 · 2008-09-24 · 1 site observation
COMPLETED
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast CancerNCT00684983 · 2008-07-30 · 1 site observation
COMPLETED
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerNCT00433511 · 2007-11-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUNCT00520975 · 2007-11-01 · 1 site observation
TERMINATED
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerNCT00516698 · 2007-09-01 · 1 site observation
COMPLETED
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00454194 · 2007-09-01 · 1 site observation
COMPLETED
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerNCT00423917 · 2007-08-01 · 1 site observation
COMPLETED
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.